(Q73754352)
Statements
Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist (English)
R G Tilton
C L Munsch
S J Sherwood
S J Chen
Y F Chen
C Wu
N Block
R A Dixon
1 January 2000